Integra LifeSciences Holdings Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IL3.F | CNMD | BVS | ARX.AX | ITGR | AVR | |
|---|---|---|---|---|---|---|
| Market cap | 1.00B | 1.60B | 781.98M | 171.82M | 4.31B | 596.45M |
| P/E (TTM) | 86.0 | 22.3 | 14.1 | 49.0 | 42.5 | — |
| Forward P/E | 3.8 | 11.3 | 12.5 | 16.8 | 18.4 | -5.3 |
| Price/book | 1.1 | 1.5 | 3.3 | 2.1 | 2.5 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +24.35% | +6.28% | +48.31% | −38.22% | +85.72% | +33.02% |
| Today | +7.50% | +13.61% | +4.34% | +1.03% | +0.07% | +9.29% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All IL3.F news ›STAAR Surgical, Integra LifeSciences, Envista, LeMaitre, and Inspire Medical Systems stocks trade up, what you need to know
FinancialContent STAAR Surgical, Integra LifeSciences, Envista, LeMaitre, and Inspire Medical Systems stocks trade up, what you need to know A number of stocks jumped in the a
Plastic Surgery Instruments Market 2025-2030 | Top Manufacturers; Zimmer Biomet Holdings Inc.; Integra LifeSciences Corporation; Wexler Surgical; Hayden Medical Inc
Plastic Surgery Instruments Market 2025-2030 | Top openPR.com Plastic Surgery Instruments Market 2025-2030 | Top Manufacturers; Zimmer Biomet Holdings Inc.; Integra LifeSciences Corporation; Wexler Surgical; Hayden Medical Inc Press…
Integra LifeSciences (NASDAQ:IART) Stock Rating Raised to “Buy” at Wall Street Zen
Posted by Defense World Staff on Oct 31st, 2026 Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday, Wall Street…
Integra LifeSciences (NASDAQ:IART) versus Embecta (NASDAQ:EMBC) Critical Review
Posted by Kim Johansen on Oct 27th, 2026 Embecta (NASDAQ:EMBC – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two…
Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting
Integra LifeSciences faces near-term operational pressures, but restructuring may unlock a contrarian 2027 upside. Click here to read more on the IART stock. - Integra LifeSciences remains pressured by operational challenges, but…
Integra LifeSciences Reports Third Quarter 2026 Financial Results
PRINCETON, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2026. Third…
More from 3 other outlets
- @kalkineus Integra LifeSciences Reports Q3 2026 Financial Results in Form 8-K Filing
- Quiver Quantitative Integra LifeSciences Reports Third Quarter 2026 Financial Results and Raises Debt Refinancing to Strengthen Liquidity
- Stock Titan Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
Integra LifeSciences Holdings Corporation Announces Completion Of Refinancing Transactions
Integra LifeSciences Holdings Corporation, on October 19, 2026, announced that it had closed a private offering of $450 million aggregate principal amount of 9.500% senior secured notes due 2033 . In... Integra LifeSciences Holdings…
Transcript : Integra LifeSciences Holdings Corporation, Q3 2026 Earnings Call, Oct 21, 2026
Presentation Operator MessageOperator Good day, and welcome to the Integra LifeSciences Third Quarter 2026 Financial Results. [Operator Instructions] Please note, this call may be recorded. I would... Integra LifeSciences Holdings…
More from 1 other outlet
Integra LifeSciences Prices $450 Million in Senior Secured Notes Due 2033
Integra LifeSciences said Monday it priced $450 million in senior secured notes at a 9.5% interest rate, maturing in 2033. The notes will constitute general senior secured obligations of the... Integra LifeSciences Holdings Corporation…
Citizens Jmp Has Lowered Expectations for Integra LifeSciences (NASDAQ:IART) Stock Price
Posted by Kim Johansen on Oct 22nd, 2026 Integra LifeSciences (NASDAQ:IART – Get Free Report) had its target price dropped by research analysts at Citizens Jmp from $25.00 to $22.00 in a report released on Thursday, Benzinga reports. The…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- seekingalpha.com5
- stocktitan.net4
- themarketsdaily.com4
- globenewswire.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 39 articles, not a forecast.